Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Advanced Medical Solutions GroupCHIX:AMSL -0.09%79 Forward Rate of Return (Yacktman) % is 16.53% as of Dec. 2025, which is 37% above its 10-year median of 12.05. GuruFocus rates CHIX:AMSL with a GF Score™ of 79/100 and a GF Value™ of £3.72 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 379 Medical Devices & Instruments companies, Advanced Medical Solutions Group ranks better than 70.18% on this metric.
Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. Advanced Medical Solutions Group's forward rate of return for was 16.53%.
The historical rank and industry rank for Advanced Medical Solutions Group's Forward Rate of Return (Yacktman) % or its related term are showing as below:
CHIX:AMSl'
s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 2.17 Med: 12.05 Max: 22.43
Current: 15.82
During the past 13 years, Advanced Medical Solutions Group's highest Forward Rate of Return was 22.43. The lowest was 2.17. And the median was 12.05.
CHIX:AMSl's Forward Rate of Return (Yacktman) % is ranked better than 70.18% of 379
companies
in the Medical Devices & Instruments industry
Industry Median: 7.94
vs CHIX:AMSl: 15.82
Unlike the Earnings Yield %, the Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Advanced Medical Solutions Group (CHIX:AMSl) Forward Rate of Return (Yacktman) % Explanation
Unlike the Earnings Yield, the Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over five years. The reason we use five years is to make it comparable to the growth rate.
Be Aware
In the Forward Rate of Return calculation, the growth rate is added directly to today's free cash flow yield. Therefore the calculation is reliable only if the company can grow at the same rate in the future as it did in the past. Investors should pay close attention to this when researching growth stocks. A more accurate measurement for return is Return on Capital.
Advanced Medical Solutions Group Forward Rate of Return (Yacktman) % Related Terms
Advanced Medical Solutions Group Forward Rate of Return (Yacktman) % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Medical Solutions Group Forward Rate of Return (Yacktman) % Chart
CHIX:AMSL vs ISRG, BDX, MDLN: Forward Rate of Return (Yacktman) % Comparison
For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's Forward Rate of Return (Yacktman) %, along with its competitors' market caps and Forward Rate of Return (Yacktman) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Medical Solutions Group Forward Rate of Return (Yacktman) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's Forward Rate of Return (Yacktman) % distribution charts can be found below:
* The bar in red indicates where Advanced Medical Solutions Group's Forward Rate of Return (Yacktman) % falls into.
Advanced Medical Solutions Group Forward Rate of Return (Yacktman) % Calculation
Forward Rate of Return is a concept that Don Yacktman uses in his investment approach. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. He said in the interview (March 2012, when the S&P 500 was at about 1400):
If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.
The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Rate of Return (Yacktman) % of 16.53% mean?
Advanced Medical Solutions Group (CHIX:AMSL) has a Forward Rate of Return (Yacktman) % of 16.53% as of Dec. 2025. Yacktman's forward rate of return equals the sum of normalized free-cash-flow yield plus earnings growth. View historical data on Advanced Medical Solutions Group and its competitors. This is 37% above median its historical median of 12.05. Over the past decade, Advanced Medical Solutions Group's Forward Rate of Return (Yacktman) % has ranged from 2.17 to 22.43. According to the industry distribution chart, Advanced Medical Solutions Group ranks #113 out of 379 companies in the Medical Devices & Instruments industry, placing it in the top 29.8%.
Is Advanced Medical Solutions Group's Forward Rate of Return (Yacktman) % too high?
Advanced Medical Solutions Group's current Forward Rate of Return (Yacktman) % of 16.53% is 37% above median its 10-year median of 12.05. Over the past 10 years, this metric has ranged from a low of 2.17 to a high of 22.43. The Medical Devices & Instruments industry median Forward Rate of Return (Yacktman) % is 7.94. Advanced Medical Solutions Group's value of 16.53% is 108.2% above this industry median. Based on the distribution chart, Advanced Medical Solutions Group ranks #113 out of 379 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Advanced Medical Solutions Group has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's Forward Rate of Return (Yacktman) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Advanced Medical Solutions Group ranks #113 out of 379 companies for Forward Rate of Return (Yacktman) %. This puts Advanced Medical Solutions Group in the upper half of its industry. The industry median Forward Rate of Return (Yacktman) % is 7.94. Advanced Medical Solutions Group's value of 16.53% is 108.2% above this benchmark. Historically, Advanced Medical Solutions Group's own Forward Rate of Return (Yacktman) % has ranged from 2.17 to 22.43 over the past decade. While the company's 10-year median is 12.05 vs. the industry median of 7.94, Advanced Medical Solutions Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Rate of Return (Yacktman) % for a Medical Devices & Instruments company?
The median Forward Rate of Return (Yacktman) % among Medical Devices & Instruments companies is 7.94, based on 379 companies in the industry. Companies in the top quartile (top 25%) have a Forward Rate of Return (Yacktman) % significantly above this median, while those in the bottom quartile fall well below. However, Forward Rate of Return (Yacktman) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Medical Solutions Group's current Forward Rate of Return (Yacktman) % of 16.53% is 108.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Rate of Return (Yacktman) % mean?
A high Forward Rate of Return (Yacktman) % can signal that a stock is expensive relative to its fundamentals. Yacktman's forward rate of return equals the sum of normalized free-cash-flow yield plus earnings growth. View historical data on Advanced Medical Solutions Group and its competitors. For the Medical Devices & Instruments industry, the median Forward Rate of Return (Yacktman) % is 7.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Medical Solutions Group's current Forward Rate of Return (Yacktman) % is 16.53%, which is 37% above median its own 10-year median of 12.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (CHIX:AMSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.72, compared to a current price of £2.81 — trading 24.5% below its estimated fair value. The current Forward Rate of Return (Yacktman) % is 16.53%, which is 37% above median its 10-year median of 12.05 and 108.2% above the Medical Devices & Instruments industry median of 7.94. Advanced Medical Solutions Group's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Rate of Return (Yacktman) % calculated?
Forward Rate of Return (Yacktman) % is calculated from a company's financial statements. For Advanced Medical Solutions Group (CHIX:AMSL), the current Forward Rate of Return (Yacktman) % is 16.53% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Medical Solutions Group (CHIX:AMSL) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued.
The current stock price of £2.81 is trading 24.5% below its estimated GF Value™ of £3.72.
GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.
Key valuation signals for CHIX:AMSL:
Forward Rate of Return (Yacktman) %: 16.53% (37% above median its 10-year median of 12.05)
GF Value™: £3.72 vs. price of £2.81 (24.5% below fair value)
Industry Position: 108.2% above the Medical Devices & Instruments median (#113 of 379)
No single metric tells the full story. See the CHIX:AMSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
79GF Score
Get the complete analysis for CHIX:AMSL
Forward Rate of Return (Yacktman) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMSL has been successfully added to your 
